Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Sumitomo Pharma Co., Ltd.

Capitalization 679B 4.24B 3.67B 3.38B 3.18B 5.91B 406B 6.01B 39.62B 15.55B 196B 15.92B 15.58B P/E ratio 2026
7.72x
P/E ratio 2027 * 7.37x
Enterprise value 833B 5.2B 4.5B 4.15B 3.89B 7.25B 497B 7.37B 48.57B 19.06B 240B 19.52B 19.1B EV / Sales 2026
2.2x
EV / Sales 2027 * 1.35x
Free-Float
51.03%
Yield 2026 *
-
Yield 2027 * 1.34%
1 day-3.83%
1 week-2.51%
Current month-10.26%
1 month-14.80%
3 months-22.46%
6 months-39.84%
Current year-37.17%
1 week 1,414.5
Extreme 1414.5
1,568
1 month 1,414.5
Extreme 1414.5
1,803.5
Current year 1,414.5
Extreme 1414.5
3,288
1 year 829
Extreme 829
3,288
3 years 279
Extreme 279
3,288
5 years 279
Extreme 279
3,288
10 years 279
Extreme 279
4,135
Manager TitleAgeSince
Chief Executive Officer 65 2024-06-24
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2022-03-31
Director TitleAgeSince
Director/Board Member 64 2025-06-24
Director/Board Member 65 2016-05-31
Director/Board Member 62 2018-05-31
Change 5d. change 1-year change 3-years change Capi.($)
-3.66%-2.51%+75.27%+124.01% 4.02B
+1.57%+6.19%+49.26%+157.85% 1,009B
-0.26%+3.87%+49.75%+44.86% 560B
-1.83%+4.76%+17.51%+62.07% 401B
+0.77%+3.06%+21.96%+15.20% 328B
-1.05%+3.78%+51.35%+8.34% 298B
-0.45%+2.69%+27.95%+17.41% 288B
-0.54%+3.02%+20.87%+29.84% 272B
-4.17%-4.53%-44.53%-50.50% 194B
-1.10%+5.04%+19.08%+56.61% 189B
Average -1.09%+1.48%+28.85%+46.57% 354.36B
Weighted average by Cap. -0.19%+3.82%+32.76%+65.27%

Financials

2026 2027 *
Net sales 441B 2.75B 2.38B 2.19B 2.06B 3.83B 263B 3.9B 25.71B 10.09B 127B 10.33B 10.11B 545B 3.4B 2.95B 2.71B 2.55B 4.74B 326B 4.82B 31.78B 12.47B 157B 12.77B 12.49B
Net income 99.3B 620M 537M 494M 464M 864M 59.31B 879M 5.79B 2.27B 28.59B 2.33B 2.28B 88.95B 555M 481M 443M 416M 774M 53.13B 787M 5.19B 2.04B 25.61B 2.08B 2.04B
Net Debt 153B 958M 830M 764M 718M 1.34B 91.67B 1.36B 8.95B 3.51B 44.18B 3.6B 3.52B 55.61B 347M 301M 277M 260M 484M 33.21B 492M 3.24B 1.27B 16.01B 1.3B 1.27B
Logo Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.
Employees
3,832
Date Price Change Volume
26-06-08 1,459.00 ¥ -3.66% 1,941,600
26-06-08 1,514.50 ¥ +5.39% 7,440,200
26-06-05 1,437.00 ¥ +1.59% 4,200,400
26-06-04 1,414.50 ¥ -3.02% 4,881,600
26-06-03 1,458.50 ¥ -2.38% 4,915,400
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,514.50JPY
Average target price
2,073.57JPY
Spread / Average Target
+36.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4506 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW